Trials / Recruiting
RecruitingNCT07357610
An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participants
- Status
- Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study is an open-label, fixed-sequence, two-period Phase 1 clinical trial in healthy adult Chinese participants with a total of 3 cohorts, 16-20 healthy adult Chinese participants are planned to be enrolled in each cohort.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SIM0270 | oral |
| DRUG | itraconazole | oral |
| DRUG | Rifampin | oral |
| DRUG | midazolam | oral |
Timeline
- Start date
- 2026-01-05
- Primary completion
- 2026-10-30
- Completion
- 2026-10-30
- First posted
- 2026-01-22
- Last updated
- 2026-01-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07357610. Inclusion in this directory is not an endorsement.